Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (31-40 of 316) with videos related to

Pageof 32
Sort By:
Clinical and Experimental Rheumatology|September 8, 2015
Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS StudyLaure Gossec, Ghislaine Steinberg, Stephanie Rouanet, et al.
Clinical and Experimental Rheumatology|January 28, 2021
Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysisGisèle Khoury, Bernard Combe, Jacques Morel, et al.
Joint Bone Spine|August 13, 2013
Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysisHelene Che, Cedric Lukas, Jacques Morel, et al.
Cytokine|May 9, 2013
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritisRachel Audo, Bernard Combe, Michael Hahne, et al.
Clinical and Experimental Rheumatology|March 31, 2018
Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature reviewBernard Combe, Sadiq Lula, Caroline Boone, et al.
The Journal of Biological Chemistry|February 3, 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/AktJacques Morel, Rachel Audo, Michael Hahne, et al.
RMD Open|November 5, 2015
Diagnostic value of ultrasound in calcium pyrophosphate deposition disease: a systematic review and meta-analysisEtienne Gamon, Bernard Combe, Thomas Barnetche, et al.
The Journal of Rheumatology|May 5, 2010
Scurvy as the presenting illness of Whipple's disease exacerbated by treatment with etanercept in a patient with ankylosing spondylitisIhsane Hmamouchi, Valérie Costes, Bernard Combe, et al.
Frontiers in Medicine|September 22, 2025
Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years oldBruno Fautrel, Alain Saraux, Isabelle Idier, et al.
Clinical and Experimental Rheumatology|January 29, 2011
Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysisAnouck Rémy, Jerome Avouac, Laure Gossec, et al.
Pageof 32

Showing results (31-40 of 316) with videos related to

Sort By:
Pageof 32
Clinical and Experimental Rheumatology|September 8, 2015
Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS StudyLaure Gossec, Ghislaine Steinberg, Stephanie Rouanet, et al.
Clinical and Experimental Rheumatology|January 28, 2021
Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysisGisèle Khoury, Bernard Combe, Jacques Morel, et al.
Joint Bone Spine|August 13, 2013
Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysisHelene Che, Cedric Lukas, Jacques Morel, et al.
Cytokine|May 9, 2013
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritisRachel Audo, Bernard Combe, Michael Hahne, et al.
Clinical and Experimental Rheumatology|March 31, 2018
Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature reviewBernard Combe, Sadiq Lula, Caroline Boone, et al.
The Journal of Biological Chemistry|February 3, 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/AktJacques Morel, Rachel Audo, Michael Hahne, et al.
RMD Open|November 5, 2015
Diagnostic value of ultrasound in calcium pyrophosphate deposition disease: a systematic review and meta-analysisEtienne Gamon, Bernard Combe, Thomas Barnetche, et al.
The Journal of Rheumatology|May 5, 2010
Scurvy as the presenting illness of Whipple's disease exacerbated by treatment with etanercept in a patient with ankylosing spondylitisIhsane Hmamouchi, Valérie Costes, Bernard Combe, et al.
Frontiers in Medicine|September 22, 2025
Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years oldBruno Fautrel, Alain Saraux, Isabelle Idier, et al.
Clinical and Experimental Rheumatology|January 29, 2011
Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysisAnouck Rémy, Jerome Avouac, Laure Gossec, et al.
Pageof 32